Mycophenolate sodium (CAS 37415-62-6)
QUICK LINKS
Mycophenolate sodium is frequently utilized in research focused on immunomodulation and cell proliferation. Within this scope, it is studied for its inhibitory effects on inosine monophosphate dehydrogenase (IMPDH), an enzyme critical for the de novo synthesis of guanosine nucleotides in lymphocytes. This specific inhibition is of interest in the exploration of pathways that influence immune response. Additionally, Mycophenolate sodium is used in investigations centered on its influence on the proliferation of various cell types, including its impact on fibroblast activity, which is pertinent in the study of fibrosis. The compound also finds utility in research aimed at understanding molecular signaling cascades and gene expression changes in response to its application in various cellular models.
Mycophenolate sodium (CAS 37415-62-6) References
- Enteric-coated mycophenolate sodium. | Gabardi, S., et al. 2003. Ann Pharmacother. 37: 1685-93. PMID: 14565799
- Review of the immunosuppressant enteric-coated mycophenolate sodium. | Budde, K., et al. 2004. Expert Opin Pharmacother. 5: 1333-45. PMID: 15163278
- Mycophenolate sodium delayed release: prevention of renal transplant rejection. | Curran, MP. and Keating, GM. 2005. Drugs. 65: 799-805; discussion 806-7. PMID: 15819592
- Enteric-coated mycophenolate sodium: tolerability profile compared with mycophenolate mofetil. | Behrend, M. and Braun, F. 2005. Drugs. 65: 1037-50. PMID: 15907141
- Enteric-coated mycophenolate sodium for transplant immunosuppression. | Ingle, GR. and Shah, T. 2005. Am J Health Syst Pharm. 62: 2252-9. PMID: 16239415
- Mycophenolate sodium for subacute cutaneous lupus erythematosus resistant to standard therapy. | Kreuter, A., et al. 2007. Br J Dermatol. 156: 1321-7. PMID: 17408395
- Myfortic (mycophenolate sodium) delayed-release tablets. | Qureshi, A. and Scheinfeld, N. 2008. Dermatol Online J. 14: 4. PMID: 19061564
- Efficacy and safety of long-term mycophenolate sodium therapy in pemphigus vulgaris. | Baskan, EB., et al. 2009. J Eur Acad Dermatol Venereol. 23: 1432-4. PMID: 19470052
- Mycophenolate sodium for immunosuppressive treatment in uveitis. | Deuter, CM., et al. 2009. Ocul Immunol Inflamm. 17: 415-9. PMID: 20001262
- Enteric-coated mycophenolate sodium. | Budde, K., et al. 2010. Expert Opin Drug Saf. 9: 981-94. PMID: 20795786
- Effects of mycophenolate sodium on mucociliary clearance using a bronchial section and anastomosis rodent model. | Silva, VF., et al. 2011. Clinics (Sao Paulo). 66: 1451-6. PMID: 21915499
- Mycophenolate Sodium for Children with Frequently Relapsing or Steroid Dependent Nephrotic Syndrome. | Kapoor, K., et al. 2017. Indian Pediatr. 54: 885-886. PMID: 29120340
- Tolerability of mycophenolate sodium in renal transplant recipients. | Hiramoto, LL., et al. 2018. Int J Clin Pharm. 40: 1548-1558. PMID: 30302621
- Pharmacokinetics of Enteric-Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN). | Ranganathan, D., et al. 2019. Ther Drug Monit. 41: 703-713. PMID: 31219949
- Mycophenolate sodium in the treatment of corticosteroid-refractory non-infectious inflammatory uveitis (MySTRI study). | Chen, TS., et al. 2020. Eye (Lond). 34: 2098-2105. PMID: 32632297
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Mycophenolate sodium, 10 mg | sc-358377 | 10 mg | $60.00 | |||
Mycophenolate sodium, 100 mg | sc-358377A | 100 mg | $200.00 | |||
Mycophenolate sodium, 1 g | sc-358377B | 1 g | $600.00 | |||
Mycophenolate sodium, 5 g | sc-358377C | 5 g | $1800.00 | |||
Mycophenolate sodium, 10 g | sc-358377D | 10 g | $3500.00 |